debrisoquin and codeine

debrisoquin has been researched along with codeine in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19901 (6.25)18.7374
1990's10 (62.50)18.2507
2000's4 (25.00)29.6817
2010's1 (6.25)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Commandeur, JN; Funae, Y; Hiroi, T; ter Laak, AM; Venhorst, J; Vermeulen, NP1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Bertilsson, L; Dahl, ML; Heim, M; Ingelman-Sundberg, M; Johansson, I; Meyer, UA; Säwe, J; Sjöqvist, F; Yue, QY1
Hasselström, J; Säwe, J; Svensson, JO; Yue, QY1
Säwe, J; Sjöqvist, F; Svensson, JO; Yue, QY1
Alm, C; Säwe, J; Sjöqvist, F; Svensson, JO; Yue, QY1
Arendt-Nielsen, L; Brøsen, K; Gram, LF; Poulsen, L; Sindrup, SH1
Caraco, Y; Sheller, J; Wood, AJ3
Brøsen, K; Sindrup, SH1
Dahl, ML; Dalén, P; Frengell, C; Sjöqvist, F1
Hasselström, J; Säwe, J; Yue, QY1
Bechtel, PR; Bechtel, Y; Berard, M; Haffen, E; Masuyer, C; Paintaud, G1
Guo, B; He, MM; Li, C; Liu, H; Shen, H; Wang, L; Wrighton, SA1

Reviews

1 review(s) available for debrisoquin and codeine

ArticleYear
The pharmacogenetics of codeine hypoalgesia.
    Pharmacogenetics, 1995, Volume: 5, Issue:6

    Topics: Analgesics, Opioid; Codeine; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Debrisoquin; Drug Interactions; Enzyme Inhibitors; Humans; Mixed Function Oxygenases; Morphine; Oxidation-Reduction; Pain; Pain Threshold; Pharmacogenetics; Phenotype; Polymorphism, Genetic; Sparteine

1995

Trials

3 trial(s) available for debrisoquin and codeine

ArticleYear
Pharmacogenetic determination of the effects of codeine and prediction of drug interactions.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 278, Issue:3

    Topics: Adult; Codeine; Cross-Over Studies; Cytochrome P-450 CYP2D6 Inhibitors; Debrisoquin; Double-Blind Method; Drug Interactions; Humans; Male; Pupil; Quinidine; Reflex, Pupillary; Respiration

1996
The effect of codeine on gastrointestinal transit in extensive and poor metabolisers of debrisoquine.
    European journal of clinical pharmacology, 1997, Volume: 53, Issue:2

    Topics: Adult; Breath Tests; Codeine; Debrisoquin; Female; Gastrointestinal Transit; Humans; Hydrogen; Male; Narcotics; Phenotype; Sympatholytics

1997
Impact of ethnic origin and quinidine coadministration on codeine's disposition and pharmacodynamic effects.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 290, Issue:1

    Topics: Adult; Analgesics, Opioid; Asian People; Biotransformation; Codeine; Cross-Over Studies; Dealkylation; Debrisoquin; Double-Blind Method; Drug Interactions; Enzyme Inhibitors; Female; Humans; Male; Morphine; Psychomotor Performance; Pupil; Quinidine; Respiratory Mechanics; White People

1999

Other Studies

12 other study(ies) available for debrisoquin and codeine

ArticleYear
Homology modeling of rat and human cytochrome P450 2D (CYP2D) isoforms and computational rationalization of experimental ligand-binding specificities.
    Journal of medicinal chemistry, 2003, Jan-02, Volume: 46, Issue:1

    Topics: Alcohol Oxidoreductases; Amino Acid Sequence; Animals; Aryl Hydrocarbon Hydroxylases; Binding Sites; Coumarins; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Enzyme Inhibitors; Humans; Isoenzymes; Kinetics; Ligands; Mixed Function Oxygenases; Models, Molecular; Molecular Sequence Data; Protein Binding; Quinidine; Quinine; Rabbits; Rats; Sequence Homology, Amino Acid; Sparteine; Species Specificity

2003
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Genetic analysis of the interethnic difference between Chinese and Caucasians in the polymorphic metabolism of debrisoquine and codeine.
    European journal of clinical pharmacology, 1991, Volume: 40, Issue:6

    Topics: Adolescent; Adult; Alleles; Asian People; Blotting, Southern; China; Codeine; Cytochrome P-450 Enzyme System; Debrisoquin; Female; Gene Amplification; Humans; Hydroxylation; Japan; Male; Metabolic Clearance Rate; Middle Aged; Phenotype; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; White People

1991
Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquine.
    British journal of clinical pharmacology, 1991, Volume: 31, Issue:6

    Topics: Administration, Oral; Adult; Codeine; Debrisoquin; Female; Half-Life; Humans; Hydroxylation; Male; Middle Aged; Phenotype; Reference Values; White People

1991
A comparison of the pharmacokinetics of codeine and its metabolites in healthy Chinese and Caucasian extensive hydroxylators of debrisoquine.
    British journal of clinical pharmacology, 1991, Volume: 31, Issue:6

    Topics: Administration, Oral; Adult; Asian People; Chromatography, High Pressure Liquid; Codeine; Debrisoquin; Female; Humans; Male; Middle Aged; Phenotype; Reference Values; White People

1991
Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation.
    British journal of clinical pharmacology, 1989, Volume: 28, Issue:6

    Topics: Adolescent; Adult; Aged; Codeine; Dealkylation; Debrisoquin; Female; Humans; Hydroxylation; Isoquinolines; Male; Middle Aged; Phenotype

1989
Are poor metabolisers of sparteine/debrisoquine less pain tolerant than extensive metabolisers?
    Pain, 1993, Volume: 53, Issue:3

    Topics: Adult; Brain; Codeine; Cold Temperature; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Debrisoquin; Female; Humans; Liver; Male; Middle Aged; Mixed Function Oxygenases; Pain; Pain Measurement; Phenotype; Sparteine

1993
Pharmacogenetic determinants of codeine induction by rifampin: the impact on codeine's respiratory, psychomotor and miotic effects.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 281, Issue:1

    Topics: Adult; Codeine; Cytochrome P-450 CYP2D6; Dealkylation; Debrisoquin; Drug Interactions; Humans; Male; Miotics; Narcotics; Pharmacogenetics; Psychomotor Performance; Respiration; Rifampin

1997
Quick onset of severe abdominal pain after codeine in an ultrarapid metabolizer of debrisoquine.
    Therapeutic drug monitoring, 1997, Volume: 19, Issue:5

    Topics: Abdominal Pain; Adult; Analgesics, Opioid; Codeine; Cytochrome P-450 CYP2D6; Debrisoquin; Female; Humans

1997
On the assessment of drug metabolism by assays of codeine and its main metabolites.
    Therapeutic drug monitoring, 2000, Volume: 22, Issue:3

    Topics: Adult; Chromatography, High Pressure Liquid; Codeine; Cytochrome P-450 CYP2D6; Debrisoquin; Dextromethorphan; Female; Glucuronides; Humans; Linear Models; Male; Methylation; Middle Aged; Morphine; Phenotype; Polymorphism, Genetic; Reproducibility of Results; Sensitivity and Specificity

2000
Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17.
    Drug metabolism and disposition: the biological fate of chemicals, 2007, Volume: 35, Issue:8

    Topics: Atomoxetine Hydrochloride; Cocaine; Codeine; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Debrisoquin; Dextromethorphan; Enzyme Inhibitors; Ethanolamines; Fluoxetine; Humans; Hydroxylation; Imipramine; Kinetics; Microsomes; Molecular Structure; Nortriptyline; Polymorphism, Single Nucleotide; Propylamines; Quinidine; Recombinant Proteins; Thioridazine; Tramadol

2007